Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving

Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving

Submitted by admin on February 10, 2015 - 8:41am
Source: 
WSJ Pharmalot
News Tags: 
patents
Big Pharma
Abilify
Amgen
AstraZeneca
Biogen Idec
Bristol-Myers Squibb
Crestor
Eli Lilly
Gilead Sciences
GSK
Harvoni
Hospira
Merck
Novo Nordisk
Pfizer
Sovaldi
Tecfidera
Headline: 
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving

Do Not Allow Advertisers to Use My Personal information